Drawing for DOSIMMUNE

USPTO serial 87942344

DOSIMMUNE

Reviewed by CopyMark Law Group

Reg. 6351022Status 700Renewal
Filing date
Status date
Registration date
May 18, 2021
Examiner
SWAIN, MICHELE LYNN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with DOSIMMUNE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*

Plus Government fees of $1,625

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Tomoko Nakajima

Tomoko Nakajima Future IP LLC4315 50th street NW Suite 100 #7777Washington, DC 20016United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical preparations for biological research, biotechnological research, medical research, pharmaceutical research, and veterinary research use, including those comprised of natural materials, but not for purposes of providing medical diagnosis or treatment, and except fungicides; chemical preparations, namely, stable isotope labeled reference standards for the analytical development of mass spectrometry methods for the biological, biotechnological, medical, pharmaceutical, and veterinary research industriesACTIVE—
005Diagnostic kits comprised of medical diagnostic chemical reagents for testing of body fluids and body tissue via high pressure liquid chromatography, for use in detecting immunosuppressant, anticoagulant, infectious, parasitic, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system and nervous system related diseases and disorders; diagnostic kits comprised of medical diagnostic chemical reagents for testing of body fluids and body tissue via liquid chromatography coupled to tandem mass spectrometry, for use in detecting immunosuppressant, anticoagulant, infectious, parasitic, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system and nervous system related diseases and disordersACTIVE—
010Medical apparatus and instruments, namely, apparatus for blood analysis, medical diagnostic apparatus for the analysis of body fluids and medical diagnostic apparatus for use in principal component analysis in biology for the analysis of body fluids; vitro diagnostic medical apparatus in the nature of mass spectrometers used in medical facilitiesACTIVE—
042Scientific research and development of molecules suitable for therapeutic use; scientific research and development of new procedures and experiments for the discovery, identification or improvement of molecules suitable for therapeutic use; scientific and medical laboratory services; engineering services in the field of custom synthesis of molecules suitable for therapeutic useACTIVE—
044Medical diagnostic testing servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 18, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 20, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 20, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
May 20, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 20, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 20, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 20, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 18, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 2, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 2, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 10, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 2, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 2, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 2, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 2, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 2, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 26, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 8, 2021MREINOTICE OF REINSTATEMENT E-MAILED—
Jan 5, 2021MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 5, 2021ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 4, 2021DMCCDATA MODIFICATION COMPLETED—
Oct 25, 2019RGRRREINSTATEMENT GRANTED - RESPONSE RECEIVED—
Oct 25, 2019D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Oct 25, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 25, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 25, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 15, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 15, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 11, 2019ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Apr 17, 2019GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Apr 17, 2019GNSIINQUIRY TO SUSPENSION E-MAILED—
Apr 17, 2019CNSISUSPENSION INQUIRY WRITTEN—
Mar 19, 2019RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Mar 8, 2019ALIEASSIGNED TO LIE—
Aug 31, 2018GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Aug 31, 2018GNSLLETTER OF SUSPENSION E-MAILED—
Aug 31, 2018CNSLSUSPENSION LETTER WRITTEN—
Aug 23, 2018DOCKASSIGNED TO EXAMINER—
Jun 6, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 4, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance